ebomi
Colour theme
Sign in
Insider · CIK 0001431819

ProQuest Associates IV LLC

CIK 0001431819 Name as filed on the most recent filing

Filed as ProQuest Associates IV LLC (34)

124 transaction lines · from 34 filings · filed 2009-12-18 to 2017-11-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2017-11-28 UroGen Pharma Ltd.
URGN 		S, Open-market sale 177,807 disposed 40.51 7,202,961.57 Form 4, filing 0000932440-17-000088
2017-11-27 UroGen Pharma Ltd.
URGN 		S, Open-market sale 31,491 disposed 41.12 1,294,909.92 Form 4, filing 0000932440-17-000088
2017-04-25 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 51,219 disposed 88.34 4,524,686.46 Form 4, filing 0000932440-17-000034
2017-04-25 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 2,961 disposed 89.09 263,795.49 Form 4, filing 0000932440-17-000034
2017-04-03 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 61,420 disposed 83.13 5,105,844.60 Form 4, filing 0000932440-17-000032
2017-03-31 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 23,689 disposed 83.02 1,966,660.78 Form 4, filing 0000932440-17-000032
2017-03-30 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 6,223 disposed 83.00 516,509.00 Form 4, filing 0000932440-17-000032
2017-03-29 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 58,755 disposed 83.01 4,877,252.55 Form 4, filing 0000932440-17-000030
2017-03-29 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 1,600 disposed 83.01 132,816.00 Form 4, filing 0000932440-17-000030
2017-03-29 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 500 disposed 83.01 41,505.00 Form 4, filing 0000932440-17-000030
2017-03-28 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 6,182 disposed 83.02 513,229.64 Form 4, filing 0000932440-17-000030
2017-03-27 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 37,731 disposed 83.00 3,131,673.00 Form 4, filing 0000932440-17-000030
2017-03-27 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 1,300 disposed 83.00 107,900.00 Form 4, filing 0000932440-17-000030
2017-03-27 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 400 disposed 83.00 33,200.00 Form 4, filing 0000932440-17-000030
2017-03-23 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 700 disposed 83.01 58,107.00 Form 4, filing 0000932440-17-000020
2017-03-21 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 500 disposed 83.10 41,550.00 Form 4, filing 0000932440-17-000020
2017-03-20 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 51,883 disposed 82.10 4,259,594.30 Form 4, filing 0000932440-17-000018
2017-03-17 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 38,997 disposed 82.01 3,198,143.97 Form 4, filing 0000932440-17-000018
2017-03-16 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 9,120 disposed 82.08 748,569.60 Form 4, filing 0000932440-17-000018
2017-01-04 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 65,114 disposed 85.16 5,545,108.24 Form 4, filing 0000932440-17-000002
2016-11-11 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 15,551 disposed 85.00 1,321,835.00 Form 4, filing 0000932440-16-000526
2016-11-10 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 15,368 disposed 85.10 1,307,816.80 Form 4, filing 0000932440-16-000526
2016-11-10 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 1,700 disposed 87.05 147,985.00 Form 4, filing 0000932440-16-000526
2016-11-10 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 1,300 disposed 85.00 110,500.00 Form 4, filing 0000932440-16-000526
2016-11-10 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 300 disposed 85.00 25,500.00 Form 4, filing 0000932440-16-000526
2016-11-10 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 167 disposed 86.00 14,362.00 Form 4, filing 0000932440-16-000526
2016-11-10 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 100 disposed 86.06 8,606.00 Form 4, filing 0000932440-16-000526
2016-11-09 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 102,919 disposed 80.09 8,242,782.71 Form 4, filing 0000932440-16-000521
2016-11-09 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 19,581 disposed 79.24 1,551,598.44 Form 4, filing 0000932440-16-000521
2016-11-09 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 11,690 disposed 76.49 894,168.10 Form 4, filing 0000932440-16-000521
2016-11-09 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 9,030 disposed 77.13 696,483.90 Form 4, filing 0000932440-16-000521
2016-11-09 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 4,200 disposed 78.23 328,566.00 Form 4, filing 0000932440-16-000521
2016-11-09 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 1,380 disposed 75.70 104,466.00 Form 4, filing 0000932440-16-000521
2016-11-07 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 5,030 disposed 75.39 379,211.70 Form 4, filing 0000932440-16-000521
2016-11-04 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 46,170 disposed 75.00 3,462,750.00 Form 4, filing 0000932440-16-000508
2016-11-02 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 146,371 disposed 70.00 10,245,970.00 Form 4, filing 0000932440-16-000508
2016-11-02 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 50,329 disposed 70.41 3,543,664.89 Form 4, filing 0000932440-16-000508
2016-11-02 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 2,100 disposed 70.00 147,000.00 Form 4, filing 0000932440-16-000508
2016-11-02 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 800 disposed 70.00 56,000.00 Form 4, filing 0000932440-16-000508
2016-09-30 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 22,100 disposed 70.06 1,548,326.00 Form 4, filing 0000932440-16-000495
2016-09-29 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 77,900 disposed 70.04 5,456,116.00 Form 4, filing 0000932440-16-000493
2016-09-21 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 97,149 disposed 66.15 6,426,406.35 Form 4, filing 0000932440-16-000485
2016-09-21 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 1,798 disposed 67.24 120,897.52 Form 4, filing 0000932440-16-000485
2016-09-21 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 654 disposed 66.17 43,275.18 Form 4, filing 0000932440-16-000485
2016-09-21 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 194 disposed 66.17 12,836.98 Form 4, filing 0000932440-16-000485
2016-09-08 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 33,796 disposed 62.33 2,106,504.68 Form 4, filing 0000932440-16-000471
2016-09-08 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 224 disposed 62.33 13,961.92 Form 4, filing 0000932440-16-000471
2016-09-08 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 66 disposed 62.33 4,113.78 Form 4, filing 0000932440-16-000471
2016-09-07 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 11,345 disposed 62.26 706,339.70 Form 4, filing 0000932440-16-000471
2016-09-07 Eagle Pharmaceuticals, Inc.
EGRX 		S, Open-market sale 75 disposed 62.26 4,669.50 Form 4, filing 0000932440-16-000471

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. ProQuest Associates IV LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001431819

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.